Patent details
301129
Product Name:
ofatumumab
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
301129
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2170388
Status:
Withdrawn
Application number:
301129
Procedural language:
Dutch
First Applicant Residence Country:
Switzerland (CH)
Marketing Authorization
1
Marketing Authorization Number:
67758
Marketing Authorization Type:
EEA
Marketing Authorization Date:
01/02/2021
Marketing Authorization Country:
Switzerland (CH)
2
Marketing Authorization Number:
67757
Marketing Authorization Type:
EEA
Marketing Authorization Date:
01/02/2021
Marketing Authorization Country:
Switzerland (CH)
3
Marketing Authorization Number:
EU/1/21/1532
Marketing Authorization Type:
EEA
Marketing Authorization Date:
29/03/2021
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
15/09/2021
First Marketing Authorization date:
01/02/2021
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
16/09/2021
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
18/09/2024
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
15/09/2021
Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 BASEL, Switzerland (CH)
Agent
1
Name:
ir. H.A. Witmans c.s.
From:
15/09/2021
Address:
V.O.
Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
2
Name:
ir. M.F.J.M. Ketelaars c.s.
From:
15/09/2021
Address:
NLO
Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:
16/09/2021
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
39/24
Publication date:
25/09/2024
Description:
Lapse or annulment
2
Bulletin Heading:
SPC
Journal edition number:
38/21
Publication date:
22/09/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date
Document type
Document Description
Number of pages
File Type
19/09/2024
Outgoing Correspondence
Letter confirmation withdrawal
1
PDF
/7/0/1/5/2/0800725107/docs/301129_11_622930l193.pdf
18/09/2024
SPC Documents
Withdrawal SPC
1
PDF
/7/0/1/5/2/0800725107/docs/301129_10_supplprotectioncertificate20240918030429224.pdf
28/08/2024
Outgoing Correspondence
Letter to applicant
3
PDF
/7/0/1/5/2/0800725107/docs/301129_9_619521l173.pdf
22/09/2021
Outgoing Correspondence
Confirmation receipt request
1
PDF
/7/0/1/5/2/0800725107/docs/301129_7_435919l174.pdf
15/09/2021
SPC Documents
Annex SPC
3
PDF
/7/0/1/5/2/0800725107/docs/301129_0_supplprotectioncertificate20210916122816990.pdf
15/09/2021
SPC Documents
Marketing Authorization SPC
3
PDF
/7/0/1/5/2/0800725107/docs/301129_1_supplprotectioncertificate20210916122816712.pdf
15/09/2021
SPC Documents
Accompanying letter SPC
2
PDF
/7/0/1/5/2/0800725107/docs/301129_2_supplprotectioncertificate20210916122816635.pdf
15/09/2021
SPC Documents
Annex SPC
2
PDF
/7/0/1/5/2/0800725107/docs/301129_3_supplprotectioncertificate20210916122816856.pdf
15/09/2021
Application Form
First filed application form
3
PDF
/7/0/1/5/2/0800725107/docs/301129_4_applicationform20210916122816476.pdf
15/09/2021
SPC Documents
Summary of the characteristics of the product
16
PDF
/7/0/1/5/2/0800725107/docs/301129_5_supplprotectioncertificate20210916122816925.pdf
15/09/2021
SPC Documents
Marketing Authorization SPC
3
PDF
/7/0/1/5/2/0800725107/docs/301129_6_supplprotectioncertificate20210916122816776.pdf
15/09/2021
SPC Documents
Annex SPC
42
PDF
/7/0/1/5/2/0800725107/docs/301129_8_supplprotectioncertificate20210916122817061.pdf